0 results available. Select is focused ,type to refine list, press Down to open the menu,
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products wor...
The following section summarizes insights on Amneal Pharmaceuticals Inc Class A's Net Income to Common Excl Extra Items:
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Net Income to Common Excl Extra Items in the financials category include:
Represents the net income or loss available to common stockholders and is arrived after adjusting preferred stock dividends and other adjustments to n...
Amneal Pharmaceuticals reported net income to common excl extra items of -116.9 M for the latest twelve months ending December 31, 2024 on its income statement.
The tables below summarizes Amneal Pharmaceuticals’s Net Income to Common Excl Extra Items and common size over the last five years:
| Fiscal Year | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2020-12-31 | 91.059 M | 1.993 B | 4.6% |
| 2021-12-31 | 10.624 M | 2.094 B | 0.5% |
| 2022-12-31 | -130 M | 2.212 B | −5.9% |
| 2023-12-31 | -83.993 M | 2.394 B | −3.5% |
| 2024-12-31 | -116.9 M | 2.794 B | −4.2% |
The tables below summarizes Amneal Pharmaceuticals’s Net Income to Common Excl Extra Items and common size over the last four quarters:
| Quarter Ending | Net Income to Common Excl Extra Items | Revenue | % Revenue |
|---|---|---|---|
| 2024-03-31 | -91.643 M | 659.2 M | −13.9% |
| 2024-06-30 | 5.994 M | 701.8 M | 0.9% |
| 2024-09-30 | -156 T | 702.5 M | 0.0% |
| 2024-12-31 | -31.081 M | 730.5 M | −4.3% |
The chart above depicts the distribution of net income to common excl extra items for companies operating in the Healthcare sector in the Developed economic region. Over 2,470 companies were considered in this analysis, and 2,379 had meaningful values. The average net income to common excl extra items of companies in the sector is -427.679 K with a standard deviation of 149 M.
Amneal Pharmaceuticals Inc Class A's Net Income to Common Excl Extra Items of -116.9 M ranks in the 8.3% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 2,479 |
| Included Constituents | 2,379 |
| Min | -382.7 M |
| Max | 1.322 B |
| Median | -5.369 M |
| Mean | -427.679 K |
| Standard Deviation | 149 M |
You can find companies with similar net income to common excl extra items using this stock screener.